Back

Klotho plasma levels are an independent predictorof mortality in women with acute coronary syndrome

31 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Women and specific aspect of cardiovascular disease Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Andrea Kallmeyer

Fundacion Jimenez Diaz University Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
Gender differences in all-cause mortality in patients with heart failure and stroke.
Mr J. Cruz (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Sex hormones and cardiovascular disease among community-based Chinese women: a cohort study
Miss T. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Risk prediction for incident hypertension following delivery using electronic health record data
Doctor J. Lewey (Philadelphia, US)
Abstract Slides Video
Presentation thumbnail
Differences between women and men with acute myocardial infarction in clinical characteristics, risk factors, and socioeconomic factors - the GENAMI Prevention Study
Doctor G. Moreno (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
The high HDL controversy continues: the prognosis for women with a high HDL profile is seriously unfavourable
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Women and specific aspect of cardiovascular disease

The Event

Event poster

ESC Congress 2025

31 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Paradoxical prognostic role of alpha-klotho protein: a marker of increased mortality risk in the post-myocardial infarction setting
thumbnail
Congress Presentation
Biochemical variables as predictors of in-hospital mortality in patients with acute coronary syndrome
thumbnail
Congress Presentation
Sex-based differences in the impact of baseline plasma uricemia on long-term mortality risk following acute coronary syndrome: a 26-year follow-up study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources